Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220
Titel:
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220
Auteur:
Overton, E.T. Kang, M. Peters, M.G. Umbleja, T. Alston-Smith, B.L. Bastow, B. Demarco-Shaw, D. Koziel, M.J. Mong-Kryspin, L. Sprenger, H.L. Yu, J.Y. Aberg, J.A.